Repositioning + Helmet Therapy for Flat Head Syndrome
Trial Summary
What is the purpose of this trial?
This study will examine how effective caregiver's repositioning strategies are in correcting an infant's deformational cranial shape, as well as the effectiveness of the use of a custom cranial remolding orthosis for treatment of deformational head shapes. Infants with torticollis will be concurrently enrolled in physical therapy treatment until the torticollis is resolved. A normal, unaffected population will be studied to compare typical growth to the growth of infants undergoing active treatment.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment for flat head syndrome?
Is helmet therapy safe for treating flat head syndrome in infants?
How does helmet therapy for flat head syndrome differ from other treatments?
Research Team
Tiffany Graham
Principal Investigator
University of Texas Southwestern Medical Center
Eligibility Criteria
This trial is for healthy infants with normal development who have flat head syndrome or torticollis but don't need physical therapy. Infants with abnormal head shapes, growth abnormalities, genetic conditions, or significant developmental delays requiring therapy cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Repositioning Therapy
Infants begin repositioning therapy and physical therapy if torticollis is present. Follow-ups occur at least monthly.
Cranial Remolding Orthosis
Infants with unresolved head shape issues may opt for cranial remolding orthosis treatment, adjusted every few weeks.
Follow-up
Participants are monitored for safety and effectiveness after treatment. Final evaluation at 12 months of age.
Treatment Details
Interventions
- Cranial Remolding Orthosis
- Repositioning Therapy
Cranial Remolding Orthosis is already approved in United States, European Union, Canada for the following indications:
- Deformational Plagiocephaly
- Brachycephaly
- Scaphocephaly
- Post-Operative Craniosynostosis
- Deformational Plagiocephaly
- Brachycephaly
- Scaphocephaly
- Deformational Plagiocephaly
- Brachycephaly
- Scaphocephaly
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Texas Southwestern Medical Center
Lead Sponsor
Children's Health
Collaborator